Manufacturing advanced therapies in Europe Phacilitate map

Advanced Therapies Manufacturing Capacity in Europe

A comprehensive guide and map showcasing Europe's growing cell and gene therapies and viral vector manufacturing landscape

There is no doubt about the strength of the pipeline of advanced therapy products, with more approvals predicted in Europe in 2019 and beyond. 

 

However, ensuring sufficient manufacturing capacity across the region and a robust infrastructure to deliver therapies at scale and where they're needed are absolutely crucial to successful commercialisation of these advanced therapies and those already on the market.

 

Where and who are the leading CMOs and viral vector manufacturers in Europe?

 

More importantly what are their capabilities and specialities? Can they manufacture at commercial scale? Who's the best partner?

 

This map is a tool for you to review the capacities, locations and specialist services of over 15 of Europe's leading CMOs and viral vector manufacturers. It's interactive too, so look out for the + while you explore!

Manufacturing advanced therapies in Europe Phacilitate map

 

Take a look at the other regional CMO maps below:

Manufacturing advnaced therapies in North America phacilitate map

North America

Japan